First Trust Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $528K | Sell |
1,746
-3,062
| -64% | -$927K | ﹤0.01% | 2250 |
|
2025
Q1 | $1.59M | Buy |
4,808
+794
| +20% | +$263K | ﹤0.01% | 1871 |
|
2024
Q4 | $1.24M | Buy |
4,014
+1,352
| +51% | +$417K | ﹤0.01% | 1990 |
|
2024
Q3 | $565K | Buy |
+2,662
| New | +$565K | ﹤0.01% | 2146 |
|
2021
Q1 | – | Sell |
-3,286
| Closed | -$365K | – | 2437 |
|
2020
Q4 | $365K | Buy |
3,286
+1,213
| +59% | +$135K | ﹤0.01% | 2185 |
|
2020
Q3 | $246K | Buy |
+2,073
| New | +$246K | ﹤0.01% | 2200 |
|
2018
Q4 | – | Sell |
-1,193
| Closed | -$255K | – | 2449 |
|
2018
Q3 | $255K | Buy |
+1,193
| New | +$255K | ﹤0.01% | 2340 |
|